Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Muna Therapeutics ApS
APS
Active
Advertising protection
CVR 41142871
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2020 · 6 years old
20 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Muna Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-14M
-29M
-43M
-57M
-50M
2021
-98M
2022
-111M
2023
-125M
2024
-61M
2025
EBITDA
DKK millions
0M
-48M
-96M
-144M
-193M
-58M
2021
-119M
-105%
2022
-136M
-14%
2023
-154M
-13%
2024
-90M
+42%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-49.693
-98.234
-110.624
-124.746
-60.636
Staff expenses
-8.756
-20.426
-25.334
-28.780
-29.340
EBITDA
-58.449
-118.660
-135.959
-153.651
-89.976
Depreciation & amort.
-3.020
-3.790
-6.559
-10.073
-4.639
EBIT
-61.469
-122.450
-142.518
-163.723
-94.615
Net financials
-4.914
-10.732
-3.233
-4.889
-36.580
Profit before tax
-66.383
-133.182
-145.751
-168.612
-131.195
Tax
-4.865
-5.500
-5.431
5.013
-5.500
Net profit
-61.518
-127.682
-140.320
-173.625
-125.695
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
184.064
247.518
168.210
175.026
311.124
Equity
162.313
202.045
126.960
18.713
-120.338
Long-term debt
0
16
0
108.080
249.775
Short-term debt
21.751
45.433
41.251
48.233
181.547
Total debt
21.751
45.449
41.251
156.313
431.322
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-8997600000.0%
This company
2021
2025
Equity ratio
-38.7%
This company
38.2%
Market median
-201% vs market
2021
2025
Return on equity
-12569500000.0%
This company
18.4%
Market median
-68312500100% vs market
2021
2025
Net profit margin (of gross profit)
-12569500000.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.19×
This company
2021
2025
Debt / equity
3.59×
This company
0.62×
Market median
-479% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Muna Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
